PRMT10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.872800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.176000E-01
Normal-vs-Stage2
1.162230E-01
Normal-vs-Stage3
3.290300E-02
Normal-vs-Stage4
8.663200E-01
Stage1-vs-Stage2
2.978800E-01
Stage1-vs-Stage3
1.263640E-01
Stage1-vs-Stage4
9.702000E-01
Stage2-vs-Stage3
1.504410E-01
Stage2-vs-Stage4
1.342980E-01
Stage3-vs-Stage4
8.151800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.977000E-01
Normal-vs-AfricanAmerican
4.936800E-01
Normal-vs-Asian
1.717240E-01
Caucasian-vs-AfricanAmerican
5.757200E-01
Caucasian-vs-Asian
4.562400E-01
AfricanAmerican-vs-Asian
3.142400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.805400E-01
Normal-vs-Female
4.422400E-01
Male-vs-Female
1.251150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.845000E-01
Normal-vs-Age(41-60Yrs)
5.842600E-01
Normal-vs-Age(61-80Yrs)
1.571580E-01
Normal-vs-Age(81-100Yrs)
2.637000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.997600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.997200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.399400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.523500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.716600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.352400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.759700E-02
Normal-vs-Daily Drinker
4.890400E-02
Normal-vs-Weekly Drinker
1.808380E-01
Normal-vs-Occasional Drinker
1.595430E-01
Normal-vs-Social Drinker
9.700800E-01
Non Drinker-vs-Daily Drinker
7.585000E-01
Non Drinker-vs-Weekly Drinker
8.648400E-01
Non Drinker-vs-Occasional Drinker
6.237800E-01
Non Drinker-vs-Social Drinker
1.312970E-01
Daily Drinker-vs-Weekly Drinker
7.019400E-01
Daily Drinker-vs-Occasional Drinker
4.780600E-01
Daily Drinker-vs-Social Drinker
1.095440E-01
Weekly Drinker-vs-Occasional Drinker
8.282200E-01
Weekly Drinker-vs-Social Drinker
1.805570E-01
Occasional Drinker-vs-Social Drinker
2.038600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.405400E-01
Normal-vs-Grade 2
6.955600E-01
Normal-vs-Grade 3
6.801800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.517770E-01
Grade 1-vs-Grade 3
2.052400E-01
Grade 1-vs-Grade 4
3.405400E-01
Grade 2-vs-Grade 3
7.346800E-01
Grade 2-vs-Grade 4
6.955600E-01
Grade 3-vs-Grade 4
6.801800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.766000E-02
Normal-vs-NonDiabetic
2.840600E-01
Diabetic-vs-NonDiabetic
5.900400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.664200E-02
Normal-vs-NoPancreatitis
2.571200E-01
Pancreatitis-vs-NoPancreatitis
8.045400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.135600E-01
Normal-vs-N1
1.018830E-01
N0-vs-N1
1.983630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.634100E-02
Normal-vs-TP53-NonMutant
7.781000E-01
TP53-Mutant-vs-TP53-NonMutant
5.517800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
